Keyphrases
Dynamical System Model
100%
MEK Inhibitor (MEKi)
100%
Combinational Therapy
100%
Oncolytic Adenovirus
100%
Combinational Cancer Therapy
100%
Coxsackievirus
75%
Adenovirus Receptor
75%
Treatment Strategy
50%
Tumor
50%
Therapeutic Efficacy
50%
Adenovirus Infection
50%
Oncolysis
50%
Clinical Trials
25%
Cancer Treatment
25%
Mitogen-activated Protein Kinase
25%
Clinically Significant
25%
Pharmacological Inhibitors
25%
Cell Death
25%
Adenovirus
25%
Mathematical Model
25%
Treatment Protocol
25%
Treatment Options
25%
Virus
25%
Tumor Cell Proliferation
25%
Advanced or Metastatic
25%
Locally Advanced
25%
Pathway Signaling
25%
Targeted Cells
25%
Receptor Expression
25%
Non-surgical
25%
Cell Interaction
25%
Further Analysis
25%
Enhanced Efficacy
25%
Virus Production
25%
Receptor-independent
25%
Competing Effect
25%
G1 Cell Cycle Arrest
25%
Oncolytic Therapy
25%
Nonlinear System of Differential Equations
25%
Infection Protocol
25%
Nonlinear Dynamic Process
25%
Medicine and Dentistry
Cancer Therapy
100%
Oncolytic Adenovirus
100%
Coxsackie Virus and Adenovirus Receptor
100%
Neoplasm
66%
Adenoviridae
66%
Combination Therapy
66%
Infection
66%
Lontucirev
66%
Virus
66%
Cell Cycle Arrest
33%
Tumor Cell
33%
Cell Proliferation
33%
Adenovirus Infection
33%
G1 Phase
33%
Cell Interaction
33%
Receptor Expression
33%
Cell Cycle Checkpoint
33%
Cell Signaling Pathway
33%
MEK Inhibitor
33%
Clinical Trial
33%
Infectious Disease Treatment
33%
Cell Death
33%
Mitogen-Activated Protein Kinase
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Infection
100%
Oncolytic Adenovirus
100%
Coxsackie Virus and Adenovirus Receptor
100%
Neoplasm
100%
Adenoviridae
66%
Lontucirev
66%
Combination Therapy
66%
Clinical Trial
33%
Mitogen Activated Protein Kinase Kinase Inhibitor
33%
Adenovirus Infection
33%
Neuroscience
Oncolytic Adenovirus
100%
Coxsackie Virus and Adenovirus Receptor
100%
Adenoviridae
100%
Cell Signaling
33%
Mitogen-Activated Protein Kinase
33%
Receptor Expression
33%
Cell Proliferation
33%
Cell Interaction
33%
Cell Cycle G1 Phase
33%
Cell Cycle Arrest
33%
Cell Death
33%
MEK Inhibitor
33%
Cell Cycle Checkpoint
33%
Biochemistry, Genetics and Molecular Biology
Adenoviridae
100%
Enterovirus
37%
Cell-Cell Interaction
12%
Clinical Trial
12%
Cell Proliferation
12%
Cell Cycle Checkpoint
12%
Cell Cycle Arrest
12%
G1 Phase
12%
Cell Death
12%
Mitogen-Activated Protein Kinase
12%
MEK Inhibitor
12%